Obesity News

Tirzepatide improved obstructive sleep apnea symptoms compared with placebo among adults with obesity, according to results from the SURMOUNT-OSA trials.

BOSTON — Intermittent fasting is a popular weight loss technique, but there are a few considerations that physicians should keep in mind when discussing it with their patients, according to a presenter at the ACP Internal Medicine Meeting.

Hundreds of clinicians will gather in Denver next week to discuss the latest treatment strategies and evidence-based approaches to obesity management.

Adults who received tirzepatide experienced greater weight loss than those who received placebo, regardless of each patient’s length of history of obesity, according to a post-hoc analysis of four SURMOUNT trials.

Individuals with obesity have long felt stigmatized and shamed in health care settings.

Incident cases of early-onset osteoarthritis have doubled globally over the last 3 decades, with the proportion of years lived with disability attributable to high BMI rising from 9.41% to 15.29%, according to data.

Treating psoriasis with oral roflumilast may induce weight loss, positioning the drug as a potentially attractive alternative for patients with psoriasis, according to a study.

People with a higher genetic risk for obesity may need to perform more physical activity to prevent obesity, according to findings published in JAMA Network Open.

Semaglutide can be covered under Medicare Part D plans to treat CVD in adults with overweight or obesity, based on new guidelines from CMS.

Apple cider vinegar might be an effective dietary intervention in the management of obesity, results from a randomized clinical study showed.